Summary
Updated Aug 31, 2026
Joseph C. Scodari is Director of Acurx Pharmaceuticals, Inc. (ACXP). 1 SEC Form 4 filing on record, dated 22 April 2026.
Trading Pattern
InsiderAlpha's records for Joseph C. Scodari go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Joseph C. Scodari has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- DM Trust Aggregator, LLC - $88.83M of BROS open-market activity in the last 90 days
- SUMMIT PARTNERS L P - $88.55M of KVYO open-market activity in the last 90 days
- Ronald Clarke - $88.51M of CPAY open-market activity in the last 90 days
- Yousif Mohammed Ali Nasser Al-Nowais - $88.47M of NESR open-market activity in the last 90 days
- Thomas J. Nimbley - $87.92M of PBF open-market activity in the last 90 days
- John Colgrove - $87.13M of P open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joseph C. Scodari?
Joseph C. Scodari is a corporate insider, tracked as Director of Acurx Pharmaceuticals, Inc. (ACXP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Joseph C. Scodari last file a Form 4?
The only primary Form 4 on record is dated 22 April 2026.
Where can I see all of Joseph C. Scodari's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joseph C. Scodari and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial